The future implications and indications of anti-vascular endothelial growth factor therapy in ophthalmic practice.
about
Microvascular complications and diabetic retinopathy: recent advances and future implicationsA review of anti-VEGF agents for proliferative diabetic retinopathyTreatment of proliferative diabetic retinopathy with anti-VEGF agents.The pathogenesis of early retinal changes of diabetic retinopathy.Changing paradigms of anti-VEGF in the Indian scenario.Reducible Polyethylenimine Nanoparticles for Efficient siRNA Delivery in Corneal Neovascularization Therapy.Ranibizumab-induced retinal reperfusion and regression of neovascularization in diabetic retinopathy: An angiographic illustration.
P2860
Q26822476-6208CFFF-A5CA-4189-A6AB-5D62F8428F94Q27025643-FADED87D-9C78-4139-B0E1-0BF91289666BQ33812021-F7C4593F-9D4B-4701-BE5F-2A360CADA70FQ34149599-F02EBDAA-64EB-4E63-A083-2635C51E04D6Q38184856-C89D86E6-E46E-44C5-8F77-07774AF50BB7Q47610066-A735C695-3A1A-4D8D-B7D0-D2FE354180BAQ50323605-AFFE294C-F96B-4605-9D54-910137C537DA
P2860
The future implications and indications of anti-vascular endothelial growth factor therapy in ophthalmic practice.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
The future implications and in ...... herapy in ophthalmic practice.
@en
type
label
The future implications and in ...... herapy in ophthalmic practice.
@en
prefLabel
The future implications and in ...... herapy in ophthalmic practice.
@en
P2860
P921
P356
P1476
The future implications and in ...... therapy in ophthalmic practice
@en
P2093
Inderjeet Kaur
Yashoda Ghanekar
P2860
P304
P356
10.4103/0301-4738.36480
P407
P5008
P577
2007-11-01T00:00:00Z